ArticleProstate international2025

Comparative adverse event profiles of triplet therapy versus docetaxel-based therapy in patients with metastatic prostate cancer: a multicenter retrospective study.

Fumihiko Urabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.